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a  b  s  t  r  a  c  t
The  molecular  basis  of  cellular  memory  is a fascinating  topic  that  progressed  with great  strides  during
the  last  few  decades.  In  the  case  of cells  of  the  immune  system,  cellular  memory  likely  extends  beyond
cell  fate determination  mechanisms,  since  immunity  can  tailor  its responses  to a potentially  hostile  envi-
ronment  that  is  a priori  variable  if not  unpredictable.  One  particularly  versatile  innate  immune  system
cell  type  is  the  macrophage.  These  phagocytes  occur  in  all organs  and  tissues  as  resident  cells  or  as  differ-
entiation  products  of  recruited  circulating  blood  monocytes.  They  come  in  many  ﬂavours  determined  by
the tissue  of residence  and by external  factors  such  as microbes.  Recently,  macrophage  epigenome  proﬁl-
ing has  revealed  thousands  of chromosomal  loci  that  are  differentially  active  in  macrophages,  revealing
chromosome  elements  that drive  macrophage  gene  expression.  The  most  dynamic  epigenomic  mark  is
nucleosomal  histone  acetylation.  This  mark is found  at gene  promoters  and  enhancers  and  correlates  very
well  with  gene  expression  changes.  A  second  mark  is H3K4me3,  which  sharply  decorates  the  promoters
of  most  protein  coding  genes  that  are (potentially)  expressed.  H3K4me3  at promoters  is  surrounded  by
its  precursor  H3K4me1.  However,  most  often  H3K4me1  occurs  without  H3K4me3  at  enhancers  where
it appears  together  with  histone  acetylation,  but  can persist  long  after  acetylation  decreased.  Hence,
the  biochemical  signal  H3K4me1  embodies  appears  to be a key  to the plasticity  of macrophage  gene
expression  potential.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  This  is  an  open  access  article  under the  CC  BY license
(http://creativecommons.org/licenses/by/4.0/).
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1. Introduction
The development of an adult organism from a zygote remains
one of the most wondrous biological phenomena. Over a century
of scientiﬁc research indicates that the molecular basis of this
extraordinary feat is coded by the respective organism’s DNA
genome. The intricate ballet of cellular migrations that occurs dur-
ing early embryogenesis produces functional cells in all organs
within one body with very high ﬁdelity. This implies that very high
levels of determinism are ultimately encoded in the DNA sequence.
Clearly, the genome harbours a detailed blueprint to make and
maintain a body. The question we will address here is how chro-
mosomes store information such as ‘memories’, with a focus on
macrophages.
2. From chromatin to chromosome domains
How does a differentiating monocyte acquire and maintain its
macrophage (Mf) identity at the hand of a DNA code common to
every other cell? Part of the answer to this question lies in the
46 human chromosomes and their biochemical milieu, namely
chromatin. The diploid human genome contains ∼6 109 bp. This
represents about 2 m of DNA, which ﬁt in a cell nucleus that is
10–20 m in diameter. Except during cell division, when chro-
mosomal DNA is highly compacted to enable sister chromatid
segregation to the daughter cells, each chromosome occupies a dis-
tinct territory within the nucleoplasm and intermingles little with
other chromosomes [1,2].
Chromosomal DNA is packaged in arrays of nucleosomes. These
are discs, ∼11 nm in diameter and 5.5 nm in height, that consist of
an octamer of histone proteins (H32-H42)(H2A-H2B)2 and ∼147 bp
of DNA [3]. The length of the linker DNA between any two nucle-
osomes varies from less than 10 to over 90 bp, with dominant
nucleosome repeat lengths of 190–200 bp in human blood cells [4].
In fact, the nucleotide composition of DNA can help to rotationally
position DNA on the nucleosome surface through phased TA, TT,
AA and GC dinucleotides positioned every 10/11 bp or multiples
thereof, suggesting that the DNA strands’ sequences themselves
can inﬂuence nucleosomal DNA packaging [5–7]. Because nucleo-
somes can stack in various solenoidal structures, some of which are
favoured by short or long linker lengths [8], arrays of nucleosome
can form higher order structures that are often modelled as one- or
two-start solenoids of polynucleosomal ﬁbres [9] that are ∼30 nm
wide [10].
Some 20,000 protein coding genes are distributed along the
length of the human chromosomes. Every gene has one or more
promoters from which transcription of mRNAs by RNA polymerase
II (RNAPII) can start [11]. Furthermore, distal elements called
‘enhancers’ modulate the activity of the promoters [12,13]. Differ-
ent cell types activate gene expression differentially by utilizing
different parts of the genome’s regulatory repertoire of cis-acting
elements. The mechanisms underlying the differential use of the
genomes’ regulatory elements involve physical changes in chro-
matin that promote or inhibit gene expression [14–16].
From a regulatory perspective, the genome is partitioned in sev-
eral thousand independently functioning ‘topologically associated
domains’ (TADs). These have been deﬁned using formaldehyde-
ﬁxed cellular chromosome restriction cleavage followed by
ligation, allowing interacting chromosome segments to be detected
as ligation products that are amenable to next-generation DNA
sequencing [17]. TADs are relatively invariant, even across mam-
malian orders such as primates and rodents [18], although it is
possible that TADs vary in conformation during ontogeny [19]. An
early study reported ∼2000 TADs ranging in size from 80 kb to
10 Mb  [18]. Considering that DNA sequences located within one
TAD are crosslinked signiﬁcantly more often than segments located
in adjacent TADs, the current model is that genes within one TAD
can be inﬂuenced by cis-acting regulatory elements within that TAD
through DNA looping, while genes outside the TAD are much less
likely to be contacted [20]. Much research indicates that a protein
ring consisting of cohesin works together with a very tight DNA
binding protein called CTCF to establish TAD boundaries, presum-
ably by forming the basis of stable chromatin loops [21–24]. It is
thought that they act as ‘boundaries’ because they can interrupt
or prevent enhancer-promoter contacts [25]. Intriguingly, inter-
chromosomal clustering of a select number of TADs marked by the
repressive H3K27me3 histone modiﬁcation has been documented
recently in embryonic stem cells [26–28]. Furthermore, some TADs
correspond to nuclear lamin associated domains [29]. The bio-
physical properties of topologically associated chromatin domains
remain to be elucidated.
3. Epigenetic mechanisms
Currently, epigenetic mechanisms encompass post-
transcriptional molecular systems, such as production of
microRNAs, which can regulate mRNAs in trans through base
pairing, leading to translation inhibition or mRNA degradation
[30]. However, most epigenetic mechanisms described to date
implicate protein-DNA interactions that affect gene expression at
the level of mRNA synthesis, either by chemically modifying DNA
bases, as is the case for 5-methyl cytosine, or by recruiting protein
complexes involved in nucleosome modiﬁcation and remodelling
that modulate chromatin structure to promote or inhibit tran-
scription initiation or elongation. The concept of epigenetics as
formulated by Conrad Waddington in 1942 for ontogenesis [31],
by Mary Lyon for X chromosome inactivation in female eutherians
[32] and by Arthur Riggs [33] and Robin Holliday [34] for 5-methyl
cytosine suggests that epigenetic mechanisms are involved in
establishing heritable chromatin states [35]. Hence, epigenetics
could be said to deal with mechanisms to establish durable
decisions, while gene control may also describe more punctual
ﬂuctuations in transcription levels. Still, the distinction between
transcription control and epigenetic control of gene expression
is probably a semantic one when considering the question at the
molecular level since nucleosomes are involved in both cases
[36]. DNA-bound histones in the form of nucleosomes are ideally
suited to perform molecular memory-related tasks because their
residence time on DNA can be of the order of many hours [37–39].
3.1. Chromatin remodelling
Nucleosomal histones can recruit proteins that harbour histone
binding domains [40–42]. When those interactions are promoted
or disrupted by post-translational modiﬁcation of histone residues
such as lysines and arginines the function of the underlying DNA
can change [43–48]. The protein domains that recognise modiﬁed
histones are commonly called ‘readers’ of the histone modiﬁ-
cations, and by analogy the enzymes that deposit and remove
the modiﬁcations are called ‘writers’ and ‘erasers’. Crucially, next
to covalent histone modiﬁcation, several sub-types of SNF2-type
ATP-dependent nucleosome remodelling enzymes are involved in
inserting and extracting histone H2A variants into existing nucleo-
somes [49–51], sliding nucleosomes along DNA [52–54], and in the
transfer of nucleosomes from one DNA segment to another [55].
Similar to histone code ‘writers’, some of the SNF2-family members
reside in large multi-subunit protein complexes that not only bind
nucleosomes to remodel them, but also harbour ‘reader’ domains
that target their activity to speciﬁcally modiﬁed nucleosomes.
A ﬁrst complicating aspect of the writer/reader system of his-
tone modiﬁcations is that ‘reader’ and ‘writer’ domains often
co-occur in the same protein complex. A second complicating
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aspect is that the ‘histone writers’ also modify non-histone factors.
In fact, the lysine and arginine residues of writers and readers are
themselves often subject to modiﬁcation [56–59].
Biochemically, writers such as methylases, acetylases, kinase,
ubiquitylases and other protein post-translational modiﬁcation
enzymes are antagonised by erasers such as demethylases, deacety-
lases, deubiquitylases, etc.  . ..  Furthermore, when one histone
lysine is the target of both acetylation and methylation, as is the
case for histone H3 lysines 9 and 27 (H3K9 and H3K27), it will take
at least two enzymatic steps to move from the repressive methy-
lated state to the activating acetylated state (or vice versa) as these
lysine modiﬁcations are mutually exclusive. Thus, it is thought that
the status quo between opposing nucleosome-modifying activ-
ities is subject to alterations by sequence-speciﬁc DNA binding
transcription factors that recruit speciﬁc chromatin modiﬁers and
remodellers to individual loci, tipping the balance towards more or
less transcription [60].
3.2. Chromatin colours
At this point it is relevant to indicate that much of the genome is
transcribed at a low level in every cell population. This ﬁnding has
been replicated many times, most conclusively by next generation
sequencing which demonstrated that indeed, most genes produce
mRNAs, albeit at a low level. For instance, in monocytes and Mfs,
∼25% of the ∼20,000 protein coding genes are detectable at a very
low level (>0.01 Reads Per Kilobase per Million sequence reads),
while about 50% of protein coding genes achieve expression levels
in excess of 1 RPKM [61]. Hence the majority of transcription units
is potentially transcribed and it is therefore more a matter of how
often transcription can take place rather than whether it takes place
at all. A black and white, open or closed, view of transcriptional
control is not consistent with the body of evidence. In fact, multiple
‘colours’ of chromatin have been described [62,63].
An example of a self-sustaining and even amplifying ‘chromatin
colour’ was initially described for the constitutive heterochromatin
mark H3K9me3, which is associated with gene repression [41]. The
concept is that the reader of this modiﬁcation can recruit the writer,
forming a positive feedback loop that allows spreading of the mark
along the length of the chromosome, as had been described in a
process called position effect variegation whereby DNA loci translo-
cated next to heterochromatin domains eventually are invaded by
the heterochromatin mark and therefore durably silenced [64]. A
more recent study provided support for a similar self-sustaining
pathway for facultative heterochromatin mark H3K27me3; the
H2A ubiquitylation activity within the H2K27me3 PRC1 ‘reader’
complex was shown to subsequently promotes H3K27me3 depo-
sition by the PRC2 ‘writer’ complex [65]. A third chromatin ‘colour’
is found at gene promoters, which are decorated with H3K4me3.
This modiﬁcation depends on H2BK120ubi1 which is itself erased
during transcription elongation by the de-ubiquitylation module of
the SAGA H3/H2B acetyltransferase complex [66–70].
Hence, nucleosomal histones can carry modiﬁcations that
favour repression (H3K9me3, H3K27me3) or activation (H3K4me1,
H3K4me3, acetylation) and these recruit ‘readers’ and ‘writers’ that
induce a particular chromatin state at a given locus, participating
in cellular signal transduction towards the genome.
3.3. Transcription initiation control
We  currently know that mRNA transcription initiation involves
histone modiﬁers, readers and remodelling complexes, gen-
eral transcription factors, and RNAPII interacting factors, which
together encompass more than 300 nuclear proteins [71]. Much
research indicates that transcription initiation sites are highly
deﬁned. Moreover, alternative initiation site usage for a gene
often correlate with cell lineage and environmental stimuli [11].
Together with general RNA polymerase II transcription factors,
the chromatin remodelling enzymes coordinate nucleosome free-
regions and participate in the chromatin transactions that take
place as transcription initiation proceeds towards elongation. The
nucleosome-free regions at transcription start sites range from 70
to 500 bp in size and usually harbour ﬂanking +1 and a −1 nucleo-
somes that are decorated with the H2A variant H2AZ and harbour
H3K4me3 [72–74]. Notably, H3K4me3 can also be detected at active
enhancers [75,76] while H2AZ is found at most accessible DNA
regions of the genome [77].
In humans, CpG islands constitute ∼70% of all gene promoter
sites. CpG islands attract H3K4me3 deposition by binding to
CFP1, which is an integral subunit of H3K4 trimethylase com-
plexes [78–80]. On the other hand, H3K4me1, which decorates
most promoter-ﬂanking nucleosome arrays and many (potentially
active) enhancers, is the product of a second set of H3K4 methylase
complexes, namely MLL3 and MLL4 harbouring complexes [80–82].
Recent proﬁling of the genome-wide occupancy of eleven mouse
SNF2-type nucleosome remodelling enzymes in embryonic stem
cells indicates that not less than six of these localise to the nucle-
osome free regions of most transcription start sites that display
H3K4me3 on their ﬂanking nucleosomes, although in three cases
occupancy was not much correlated with actual gene expression
levels [74]. Ep400, which does correlate with transcription activ-
ity, modulates H2A-H2AZ variant substitution and is part of a very
large protein complex that also harbours the TIP60/KAT5 histone
H4/H2A acetyltransferase [83–86]. Chd4, whose occupancy does
not correlate directly with transcript levels, is a subunit of the NURD
complex that also contains a pair of histone deacetylases (HDAC1
and HDAC2) alongside multiple ancillary subunits [56,87–89]. It
remains to be determined in what sequence all these SNF2 ATPase
come into play at gene promoters.
The ENCODE project performed chromatin immuoprecipitation
of sequence-speciﬁc transcription factors and showed that they
constantly scan nucleosome free regions [90]. At nucleosome free
regions, activation and repression domains of the transcription
factors recruit or activate a diverse set of enzymes. Commonly
encountered targets are subunits of the evolutionarily conserved
multi-subunit general transcription factors called ‘the mediator’
and the P-TEFb elongation factor [91]. Like the TFIIH helicase
which is involved in RNAPII initiation, mediator and P-Tefb harbour
specialised cyclin–cyclin dependent kinase protein pairs whose
primary function is to phosphorylate the ∼50 C-terminal domain
heptapeptide repeats of the large subunit of RNAPII [92–97]. A
large body of literature indicates that transcription factors are able
to recruit histone modifying and remodelling activities [98,99].
Understanding the exact mechanisms by which transcription fac-
tors bound to promoters and enhancers stimulate transcription
remains an active ﬁeld of investigation [100,101].
3.4. Transcription control elements on chromosomes as sites of
molecular memory storage
To establish long-term memories in the brain, neurons need
to remodel their connections with other neurons. It has been
shown that this process requires transcription and relies on histone
methylases that deposit H3K4me3 at gene promoters [102–104].
Hence, also in the brain, epigenetic enzyme activity is key in
the storage of memories, presumably because nucleosome-based
transcription control enables ﬁxation of a transiently perceived
molecular signal via altered gene expression in the following
hours/days. More generally, it may  be that the complex and
highly coordinated set of protein–protein interactions that was ﬁrst
described to regulate gene expression potential in lower eukaryotes
[105–108] can result in some level of self-sustaining topological
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and chemical bookmarking of the human genome’s promoters and
enhancers.
A straightforward class of models posits that in any cell type, a
status quo is attained at all genes in the genome. This status quo can
be biased towards transcription activation or towards repression,
depending on the local concentration of opposing activities that
control rate-limiting steps in the process of transcription. Hence,
cell type-speciﬁc expression of histone ‘writer’ or ‘reader’ complex
subunits may  well be an important key to cellular fate ﬁxation as
this would modulate the activity of subsets of sequence speciﬁc
DNA binding transcription factors that are already present in the
cell but miss the presence of a particular chromatin remodelling
complex (isoform) to inﬂuence gene expression [109–112].
Two memory-related questions can be asked at this point. How
do cells manage to hold on to their identity and avoid becoming
an unrelated cell type? A second question is how cells such as
macrophages remember environmental signals they perceived in
the past [113]? An emerging ﬁrst answer to both questions is that
the ∼1600 human TF genes (and the splice-isoforms they can give
rise to) together with the chromatin remodelling factors that write,
erase and read nucleosomal histone modiﬁcations are enough to
explain the determination and differentiation of all the human cell
types [114–116]. However, since a cell not only consists of chro-
matin and transcription factors, much more comes into play to
maintain cell identity. Hence, RNA processing, transport and trans-
lation as well as non-transcription related interactions have the
potential to form stable regulatory networks that can help perpet-
uate a given memory. Secondly, cells are embedded in a predictable
environment consisting of other cells and tissue components, form-
ing a complex environment that they can sense and to which they
contribute. Thirdly, temporal sequences of cellular events are likely
inbuilt in the epigenetic programs, so as to permit homeostasis in
the long term by providing a predictable physiological outcome
such as tissue turnover or repair. Hence, once a choice is made,
a cells’ transcription factor network and its epigenetic program
lead down a predetermined path [31]. Elucidation of the programs
associated with the multitude of cell fates is a task for the present
times.
4. Macrophage epigenomes
Macrophages (Mfs) and related phagocytes exist in both pro-
terostome and deuterostome animals. In mammals, embryonically
determined microglia in the brain, Kupfer cells in the liver and
tissue-resident Mfs  and dendritic cells, as well as osteoclast in the
bones are examples of phagocytic cell types derived from the meso-
dermal lineage that performs haematopoiesis, the generation of
blood cells [117,118]. Haematopoiesis branches out to form many
cell types from one multipotent stem cell [119]. Our understanding
of haematopoiesis, and in particular the non-lymphoid lineages, has
progressed greatly thanks to recent single cell transcriptome anal-
yses and mouse transplantation experiments, revealing a nested
system of decision-making processes [20,120–123]. Furthermore,
epigenomic characterisation revealed great plasticity in the epige-
netic programs of Mfs  that consist of >10,000 enhancers whose
activity changes when mouse Mfs  are transplanted from one organ
to another [124]. This is in keeping with the proposition that Mfs
are very receptive to their tissue environment [16,125–129].
For more than a decade we have known the signature of histone-
encoded signals at gene promoters and enhancers [130,131].
Currently, within the international human epigenome consortium
(IHEC) and associated projects such as the European BLUEPRINT
project, puriﬁed cell populations from healthy donors are being
proﬁled for epigenetic marks along their chromosomes [132,133].
Addition of nuclease DNA accessibility data [134–136] alongside
the nucleosome-borne information revealed that many acetylated
and methylated nucleosomes at promoters and enhancers are
adjacent to non-nucleosomal, highly accessible DNA stretches.
Altogether, this provides accurate epigenome maps. Epigenome
maps represent important information resources because they
reveal the genetic pathways that are active as well as those that
can be activated through further transcription factor binding [137].
Such anticipation of possible future events is the basis for a type of
cellular memory that is thought to be important for innate immune
memory and medicine because environmental signals, and the
resulting epigenomic marks, are potentially amenable to pharma-
cological intervention when innate immune system cells are too
active or not active enough [138].
Until recently, the powerful DNA rearrangement-mediated
memory features of lymphoid cells overshadowed the potential
for adaptive memory phenomena – that do not involve DNA rear-
rangements – in myeloid cells. During inﬂammation, monocytes
differentiate into macrophages (Mfs) in the absence of cell division.
Recent research underscores the capacity of adult monocytes not
only to adapt their behaviour upon exposure to microorganism-
associated molecular patterns (MAMPs) but also to consequently
give rise to Mfs  with different functionalities [139]. In fact, even
invertebrate organism Mfs  may  undergo developmental training
through engulfment of apoptotic embryonic cells, which appears
to empower subsequent infectious bacteria phagocytosis [140].
Besides autonomic and tissue patterned cell fate determination
mechanisms, innate immune cells such as Mfs  must tailor their
response to a potentially hostile environment that is a priori vari-
able if not unpredictable due to the plethora of commensal and
pathogenic microbes and viruses they may  encounter. To address
this issue, we  integrated the transcriptomes and the epigenomes
of three populations of Mfs  that were derived in vitro from healthy
adult human monocytes. The monocyte to Mf  differentiation condi-
tions consisted of 6 days of cultivation in 10% pooled human serum,
and differed only in the fact that the monocytes were exposed to
beta-glucan (BG), a fungal cell wall component, or to lipopolysac-
charide (LPS), a bacterial cell wall component, during the ﬁrst 24 h
of in vitro culture. The third populations served as unexposed con-
trol. At the sixth day of this protocol, Mfs  derived from BG-treated
monocytes are more pro-inﬂammatory and better phagocytes than
the control cells [139]. Hence they are said to be trained, a con-
cept with applications in vaccination [141]. On the other hand, Mfs
derived from monocytes treated with LPS secrete lower levels of
IL6 and TNF than the control Mfs. They are said to be tolerant, a
concept that has been linked to sepsis-induced immune paralysis
[138]. In both instances, the Mfs  studied on day 6 appear to ‘remem-
ber’ their precursor cell’s encounters with microbes during the ﬁrst
day of the experiment.
In total, 3.8 106 bp (0.12% of the human genome) undergo
nucleosome-borne epigenomic dynamics following exposure to
MAMPs  [61]. As output, 12% of the transcriptome was different
(4-fold change, p < 0.05) between the three Mf subtypes. There-
fore, a sizable proportion of the human chromatin and Mf  gene
expression program is affected upon detection of microorganisms.
Indeed, trained, control and tolerant Mfs  display transcriptomic
differences at all investigated levels, going from their interac-
tions potential with the extracellular matrix to signal receptors
and metabolite transporters at their plasma membrane, through
organelle and cytoplasm constituents and the signalling pathways
they harbour all the way  down to RNA processing and transcrip-
tion factor constellations, altogether resulting in the establishment
of reproducible Mf  fate trajectories.
Training due to BG treatment induces H3K27 acetylation at more
than 3000 enhancer loci, generating a large exclusive signature.
The genes targeted by these enhancers are generally also active in
the other Mfs, however, indicating a positive modulating role on
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gene expression and rarely all or nothing gene activation events.
Likewise, LPS-induced nucleosome acetylation increases at some
500 loci. For the endotoxin tolerant Mfs  obtained by pre-treatment
of the monocyte precursor cells with LPS, these changes often
involve sustained expression of genes that were already active in
monocytes, but now through newly established enhancers that are
unique to the tolerant Mfs  [61].
Besides H3K27 acetylation, which reports both enhancer and
promoter activity, H3K4me3 marks >20,000 promoter loci, deco-
rating the promoters of all the genes whose expression is detected
at the RNA level in the monocyte-derived Mfs. Contrary to the sharp
H3K4me3 peaks encompassing less than 3 nucleosomes (median
350 bp), H3K4me1, a precursor of the promoter H3K4me3 mark,
is distributed over larger regions (median 3.5 kb). Interestingly,
H3K4me1 marking, persists long after H3K27ac signals dimin-
ished [61]. As suggested for by Gioacchino Natoli [142], H3K4me1
embodies mid- to long-term epigenetic activity, perhaps by facil-
itating ulterior (re)activation of a transcription start site or an
enhancer, a state referred to as latency. Nevertheless, this mark
can be transient [15].
Are there key orchestrators of the Mf  epigenome? Yes, in
total more than 200 TFs, 100 kinases and 20 epigenetic enzymes
were differentially expressed after monocyte to Mf  differentia-
tion [61]. For instance, the KDM6B/JMJD3 lysine de-methylase is
rather uniquely expressed in monocytes and the E-box binding
C2H2 zinc ﬁnger TF SNAI1 of monocytes is largely replaced by
its SNAI3 paralog in Mfs. The NFKB regulator IRAK3 is epigeneti-
cally and transcriptionally upregulated in endotoxin paralysed Mfs,
and G-coupled receptors, such as the Adora receptors, and many
cAMP signal transduction factors are expressed differentially by
BG trained Mfs  relative to control and paralyzed Mfs  [61]. Fur-
thermore, the trained cell’s metabolism is remodelled; including
increased glycolytic capacity, cytoplasmic malate and isocitrate
dehydrogenases and cholesterol metabolizing enzymes [61,143].
These and other metabolic changes are themselves likely to impact
the dynamics of chromatin modiﬁcations through altered availabil-
ity of co-factors for the writers and erasers of histone modiﬁcations
[82,144–146].
5. Conclusions and perspective
We  have known the ∼20,000 human protein coding genes for
more than 15 years, but are just now starting to discover all the
regulatory DNA sequences that make up enhancers and promoters
that control their expression. It is well established that enhancer
and promoter usage is a deﬁning property of cell lineages and
sub-types [147]. Hence, comprehensive functional annotation of
the epigenomically active loci will greatly impact diagnostic and
prognostic tool development because novel fundamental knowl-
edge about the inner workings of human cells will undoubtedly
be revealed [148]. Within cellular chromatin, we can use generic
technologies to systematically map  accessible regions [136,149],
nucleosome-borne epigenetic signals [130,150], post-replicational
5-cytosine methylation [151,152] as well as looping interactions
between enhancers and promoters [17]. Developing these new
molecular biology resources through annotation in well-curated
databases will extend our knowledge considerably. This can then be
integrated with the human TF repertoire recognition motifs [153],
and with knowledge on the chromatin remodelling enzymes that
are recruited by TFs, to provide models of molecular signal trans-
duction pathways where the DNA elements have importance on
par with that of proteins. Very recently, a European COST action
has been awarded to push these issues forward in a globally coor-
dinated open context (www.cost.eu/COST Actions/ca/CA15205).
Chromatin vocabulary box.
Transcription start site (TSS):  Site where DNA transcription
begins.
Transcription factor binding motif:  DNA sequence motif
recognized by proteins.
Histone modiﬁcation:  Nucleosome-bound molecular infor-
mation consists of histone amino acid post translational
modiﬁcations, of which more than 60 have been described to
date.
DNA Accessibility: Obtained through observed accessibility
to experimental probes. Is a region more likely to be bound by
TFs than by nucleosomes. Nucleosome depleted regions, a.k.a.
nucleosome free regions, occur at active TSSs and enhancers.
Promoter:  DNA sequence for productive transcription initia-
tion. The coordinates for a promoter must encompass at least
one TSS, but extend to encompass adjoining DNA sequence
and nucleosome-encoded molecular information.
Enhancer:  Operational sequence that encompasses DNA- and
nucleosome-borne information and which is capable of inﬂu-
encing juxtaposed promoter activity. Enhancers are devoid of
functional TSS for mRNAs, although enhancers may  be tran-
scribed [154].
Differentially modiﬁed DNA: Deﬁned by the extent of
cytosine or other nucleobase post-replicational covalent mod-
iﬁcation.
Loops to:  topological notation for binary or higher order inter-
action between deﬁned DNA elements.
Topologically associated domains (TADs): All the DNA
located within a TAD is more likely to interact with other DNA
sequences within the same TAD than with DNA located outside
this TAD.
Boundary: DNA sequence that delimits one side of a TAD.
Legend: Although the protein-DNA interactions that guide gene
expression are extraordinarily intricate, when viewed from a DNA
point of view, the number of possible transactions is small. The
transactions involve distinct cis-acting DNA elements (promoters,
enhancers, boundaries) that engage in higher order loops that are
controlled by DNA-bound proteins. Operationally, a silencer may
be a negatively acting enhancer, but it may  also be a conditional
boundary that can interrupt the looping interaction between a pro-
moter and an enhancer. Similarly, decommissioning of a boundary
may  lead to gene activation, as this would permit novel promoter-
enhancer loops to be formed [100].
Finally, an important corollary of epigenome proﬁling is that
once DNA loci that function in regulation of speciﬁc cell behaviour
have been catalogued (See vocabulary box), the genetic variation
in these regions within the human population can be investigated
too [149]. Since the majority of human variation resides outside
the protein coding DNA we  may  then start to understand human
biology much more deeply than we  currently do.
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